We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Manufacturer Cited for Out-of-Spec Operations
Manufacturer Cited for Out-of-Spec Operations
July 9, 2008
Midland Pharmaceutical made significant modifications to critical production parameters for its unapproved version of antibiotic sulfamethoxazole/trimethoprim without evaluating their impact through its change control system, according to a recent warning letter.